eCQMs for 2020 Performance Period CMS2v9 CMS22v8 CMS50v8 CMS52v8 CMS56v8 CMS66v8 CMS68v9 CMS69v8 CMS74v9 CMS75v8 CMS82v7 CMS90v9 CMS117v8 CMS122v8 CMS124v8 CMS125v8 CMS127v8 CMS128v8 CMS129v9 CMS130v8 CMS131v8 CMS132v8 CMS133v8 CMS134v8 CMS135v8 CMS136v9 CMS137v8 CMS138v8 CMS139v8 CMS142v8 CMS143v8 CMS144v8 CMS145v8 CMS146v8 CMS147v9 CMS149v8 CMS153v8 CMS154v8 CMS155v8 CMS156v8 CMS157v8 CMS159v8 CMS160v8 CMS161v8 CMS165v8 CMS177v8 CMS249v2 CMS347v3 CMS349v2 CMS645v3 CMS771v1 CMS Measure ID CMS129v9 Version 9 NQF Number 0389e Measure Description Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer Initial Population All patients, regardless of age, with a diagnosis of prostate cancer Denominator Statement Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy Denominator Exclusions None Numerator Statement Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer Numerator Exclusions Not Applicable Denominator Exceptions Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, bone scan ordered by someone other than reporting physician) Measure Steward PCPI(R) Foundation (PCPI[R]) Domain Efficiency and Cost Reduction Previous Version CMS129v8 Measure Scoring Proportion Measure Type Process Improvement Notation Higher score indicates better quality Guidance A higher score indicates appropriate treatment of patients with prostate cancer at low (or very low) risk of recurrence. Only patients with prostate cancer with low (or very low) risk of recurrence will be counted in the performance denominator of this measure. Quality ID 102 Meaningful Measure Appropriate Use of Healthcare Specifications Attachment Size CMS129v9.html 53.93 KB CMS129v9.zip 34.88 KB CMS129v9-TRN.xlsx 21.63 KB Release Notes Header Updated eCQM version number. Measure Section: eCQM Version number Source of Change: Measure Lead Added 'e' to NQF number. Measure Section: NQF Number Source of Change: Standards Update Updated description statement with removal of references to cryotherapy to align with the updated guideline. Measure Section: Description Source of Change: Expert Work Group Review Updated copyright. Measure Section: Copyright Source of Change: Annual Update Updated disclaimer. Measure Section: Disclaimer Source of Change: Measure Lead Updated rationale statement with in-text citation date to reflect updated reference. Measure Section: Rationale Source of Change: Measure Lead Updated clinical recommendation statement to align with current guidelines. Measure Section: Clinical Recommendation Statement Source of Change: Measure Lead Updated references to align with American Psychological Association (APA) style. Measure Section: Reference Source of Change: Measure Lead Updated references. Measure Section: Reference Source of Change: Measure Lead Updated definition statement to align with current guideline. Measure Section: Definition Source of Change: Measure Lead Updated denominator statement with removal of references to cryotherapy from the denominator statement to align with updated guideline. Measure Section: Denominator Source of Change: Expert Work Group Review Updated parenthetical citations to align with American Psychological Association (APA) style. Measure Section: Multiple Sections Source of Change: Measure Lead Logic Replaced value set Cancer Staging (2.16.840.1.113883.3.526.3.1536) with direct reference code SNOMED CT code (258232002). Measure Section: Denominator Source of Change: Measure Lead Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with CQL Style Guide. Measure Section: Definitions and Functions Source of Change: Standards Update Updated Clinical Quality Language (CQL) expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 3 (CQL 1.3). Measure Section: Multiple Sections Source of Change: Standards Update Value Set The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets. Value set Prostate Cancer Treatment (2.16.840.1.113883.3.526.3.398): Deleted 1 CPT code (55873). Added 2 SNOMED CT codes (427541000119103, 764675000) and deleted 8 SNOMED CT codes (169374002, 176319004, 265589001, 29860002, 420529003, 427357007, 433225000, 64978007). Measure Section: Terminology Source of Change: Annual Update Value set Pain Related to Prostate Cancer (2.16.840.1.113883.3.526.3.451): Deleted 2 ICD-9-CM codes (V76.44, V84.03). Deleted 2 ICD-10-CM codes (Z12.5, Z15.03). Measure Section: Terminology Source of Change: Annual Update Replaced value set Cancer Staging (2.16.840.1.113883.3.526.3.1536) with direct reference code SNOMED CT code (258232002). Measure Section: Terminology Source of Change: Measure Lead Removed code system versions from direct reference codes. Please refer to Appendix A of the Electronic Clinical Quality Measure Logic and Implementation Guidance document for a list of code system versions used in the eCQM specifications for 2020 reporting/performance. Measure Section: Terminology Source of Change: Standards Update Standardized purpose statement language in value sets across eCQMs. Value set purpose statements are visible in the Value Set Authority Center (VSAC) as well as the downloadable eCQM value set files. Measure Section: Terminology Source of Change: Measure Lead External Resources United States Health Information Knowledgebase NLM Value Set Authority Center (VSAC)